Integrated gene-metabolite association network analysis reveals key metabolic pathways in gastric adenocarcinoma

Botao Xu1, Yuying Shi2,3,4, Chuang Yuan5

  • 1Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, China.

Heliyon
|September 25, 2024
PubMed

Insights

This study maps gene-metabolite networks in gastric cancer, identifying key pathways and biomarkers. Understanding these metabolic disruptions aids in developing new diagnostic and therapeutic strategies for this deadly cancer.

Area of Science:

  • Oncology
  • Metabolomics
  • Systems Biology

Background:

  • Gastric adenocarcinoma is a leading cause of cancer mortality globally.
  • Metabolomics offers insights into cancer progression and biomarker discovery through small molecule profiling.
  • Understanding disrupted metabolites is crucial for deciphering gastric cancer's cellular mechanisms.

Purpose of the Study:

  • To construct a knowledge-based gene-metabolite association network for gastric cancer.
  • To identify key gene-metabolite pathways and associated molecules in gastric cancer.
  • To facilitate mechanistic investigation and understanding of metabolic biomarkers in gastric cancer.

Main Methods:

  • Construction of a gene-metabolite association network using dysregulated genes and metabolites from gastric cancer patients and controls.
  • Application of topological pathway analysis.
  • Utilizing gene-protein-metabolite-disease association analysis.

Main Results:

  • A knowledge-based gene-metabolite association network for gastric cancer was successfully constructed.
  • Four key gene-metabolite pathways involving eleven metabolites and modulated genes were identified.
  • The network provided a comprehensive overview of molecular mechanisms in gastric cancer.

Conclusions:

  • The integrated gene-metabolite network facilitates mechanistic investigation of gastric cancer.
  • This approach enhances the understanding of metabolic biomarker roles in gastric cancer.
  • Findings support the development of targeted diagnostics and therapeutics for gastric cancer.